Financials data is unavailable for this security.
View more
Year on year Kuangli Bio Tech Holdings Co Ltd 's revenues fell -14.26% from 342.16m to 293.37m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 68.72m to a larger loss of 104.16m.
Gross margin | 16.26% |
---|---|
Net profit margin | -52.49% |
Operating margin | -55.73% |
Return on assets | -13.97% |
---|---|
Return on equity | -28.39% |
Return on investment | -18.88% |
More ▼
Cash flow in TWDView more
In 2023, cash reserves at Kuangli Bio Tech Holdings Co Ltd fell by 78.67m. Cash Flow from Financing totalled 17.52m or 5.97% of revenues. In addition the company used 62.36m for operations while cash used for investing totalled 30.51m.
Cash flow per share | -1.10 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 7.57 |
---|---|
Tangible book value per share | 3.46 |
More ▼
Balance sheet in TWDView more
Current ratio | 1.01 |
---|---|
Quick ratio | 0.8451 |
Total debt/total equity | 0.747 |
---|---|
Total debt/total capital | 0.4276 |
More ▼